Alteogen Inc.

Alteogen Inc.
Stock Exchange Korea Exchange
EPS
KRW789
Market Cap
KRW431.13 B
Shares Outstanding
12.64 M
Public Float
7.82 M

Profile

Address
62 Yuseong-daero 1628beon-gil
Daejeon DE 34054
Korea, Republic Of
Employees -
Website http://www.alteogen.com
Updated 09/14/2018
Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.

Financials

View All

Sun-Jae Park
Chief Executive Officer & Director
Jong-Yoon Park
Chief Financial Officer & Director